Revenue
2019
2020
2021
2022
2023
2024
2025
BIOADAPTIVES, INC. (BDPT)
Price—Loading quote
Net income
2015
2019
2020
2021
2022
2023
2024
2025
Free cash flow
2014
2024
2025
Total cash / debt
CashTotal debt
2015
2019
2020
2021
2022
2023
2024
2025
Financial statements
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2015 | 2014 | |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | $18,278 | $12,669 | $28,565 | $17,176 | $19,776 | $16,327 | $9,934 | — | — |
| Gross profit | $12,497 | $4,030 | $10,819 | $7,126 | $10,105 | $6,095 | $4,885 | — | — |
| Operating expenses | $1.1M | $606,120 | $239,740 | $429,026 | $646,186 | $260,421 | $239,292 | $227,276 | $2.4M |
| Operating income | −$1.0M | −$602,090 | −$228,921 | −$421,900 | — | — | — | −$227,276 | −$2.4M |
| EBITDAderived | −$1.0M | −$600,149 | — | — | — | — | — | — | — |
| Net income | −$1.6M | −$899,161 | −$712,466 | −$895,570 | −$1.0M | −$847,244 | −$238,927 | −$227,432 | −$2.6M |
| Basic EPSper diluted share | — | -$0.11 | -$0.12 | — | — | -$0.04 | -$0.01 | -$0.02 | -$0.21 |
| Diluted EPSper diluted share | -$0.15 | -$0.11 | — | — | — | -$0.04 | -$0.01 | -$0.02 | -$0.21 |
Insider buys & sells
| Transaction | Insider | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| Apr 9, 2025Form 4 | FRISSORA MARK PDirector | BuyOption to Purchase Common Stock · derivative | 1 | — | — | 1 |
| Apr 9, 2025Form 4 | FRISSORA MARK PDirector | BuySeries D Convertible Preferred Stock · derivative | 39.9K | $7.52 | $299.8K | 44.4K |
| Nov 22, 2024Form 4 | Dissanayake Gimhana SasankaDirector | BuyCommon | 125.0K | $0.09 | $11.3K | 125.0K |